Position in ELAN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,630,311
-$22,784,765 QoQ
Shares Held
391,317
-72.7% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 518 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. ELAN ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in ELAN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,630,311 | 391,317 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $32,415,076 | 1,432,394 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $12,502,254 | 875,508 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $34,734,462 | 3,308,044 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $47,424,431 | 3,916,138 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $52,446,796 | 3,570,238 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $55,946,726 | 3,877,112 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $65,026,178 | 3,994,237 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $62,510,133 | 4,195,311 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $47,708,966 | 4,244,570 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $42,515,209 | 4,226,164 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $39,746,960 | 4,228,400 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $82,309,007 | 6,735,598 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $83,011,731 | 6,689,100 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $99,346,527 | 5,060,954 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $122,107,774 | 4,680,252 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $120,639,321 | 4,250,857 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $138,452,794 | 4,341,574 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $171,112,934 | 4,932,630 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $146,367,707 | 4,970,041 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $266,075,898 | 8,675,445 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $102,982,993 | 3,687,182 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $85,243,415 | 3,974,052 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $91,276,663 | 4,076,671 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||